<DOC>
	<DOCNO>NCT02322008</DOCNO>
	<brief_summary>Can genetic marker use predict anti-TNF response ? A cohort establish identify SNPs associate anti-TNF therapy patient inflammatory bowel disease .</brief_summary>
	<brief_title>Anti-TNF Therapy Danish Patients With Inflammatory Bowel Diseases Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>CD UC , treat antiTNF Missing data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>